newsfilter
← Latest News
Business Wire·

Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results

- Poster presentations highlight clinical data across Cybin's CYB003 deuterated psilocin and DMT programs - Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough